Federal Circuit says ‘patent dance’ is optional

22-07-2015

Federal Circuit says ‘patent dance’ is optional

360b / Shutterstock.com

The US Court of Appeals for the Federal Circuit has ruled that biosimilar applicants can opt out of the so-called patent dance, paving the way for Sandoz to sell a biosimilar version of an Amgen drug.


Sandoz, Amgen, Neupogen, patent dance, BPCIA, US Court of Appeals for the Federal Circuit

LSIPR